BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29475551)

  • 21. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt (Tips) Creation Using Fluency Versus Viatorr Stent-Grafts: A Single-Centre Retrospective Study.
    Wu HM; Huang SQ; Wan YM; Li YH; Xu Y
    Cardiovasc Intervent Radiol; 2022 May; 45(5):552-562. PubMed ID: 35274174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of covered stent length in portal and hepatic veins on long-term clinical efficacy of transjugular intrahepatic portosystemic shunt].
    Hu P; Chen SL; Lin ZP; Zhao JB; Chen Y; He XF; Zeng QL; Li YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1444-1448. PubMed ID: 27777214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased Survival.
    Trebicka J; Bastgen D; Byrtus J; Praktiknjo M; Terstiegen S; Meyer C; Thomas D; Fimmers R; Treitl M; Euringer W; Sauerbruch T; Rössle M
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2793-2799.e1. PubMed ID: 30940552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.
    Wang CM; Li X; Fu J; Luan JY; Li TR; Zhao J; Dong GX
    Chin Med J (Engl); 2016 Jun; 129(11):1261-7. PubMed ID: 27231160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
    Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts.
    Bercu ZL; Fischman AM; Kim E; Nowakowski FS; Patel RS; Schiano TD; Chang CY; Lookstein RA
    AJR Am J Roentgenol; 2015 Mar; 204(3):654-61. PubMed ID: 25714299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
    Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial.
    Riggio O; Ridola L; Angeloni S; Cerini F; Pasquale C; Attili AF; Fanelli F; Merli M; Salvatori FM
    J Hepatol; 2010 Aug; 53(2):267-72. PubMed ID: 20537753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covered
    Qi X; Tian Y; Zhang W; Yang Z; Guo X
    Therap Adv Gastroenterol; 2017 Jan; 10(1):32-41. PubMed ID: 28286557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The retrospective study of transjugular intrahepatic portosystemic shunt with covered or uncovered stents in patients with portal hypertension].
    Wu XJ; Cao JM; Han JM; Huang Q; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):83-7. PubMed ID: 20302722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of the medium-term curative effect of transjugular intrahepatic portosystemic shunt through jugular vein with covered Viatorr stent].
    Lin ZP; Zhao JB; Chen SL
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):440-444. PubMed ID: 31357760
    [No Abstract]   [Full Text] [Related]  

  • 35. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.
    Angermayr B; Cejna M; Koenig F; Karnel F; Hackl F; Gangl A; Peck-Radosavljevic M;
    Hepatology; 2003 Oct; 38(4):1043-50. PubMed ID: 14512892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.
    Andring B; Kalva SP; Sutphin P; Srinivasa R; Anene A; Burrell M; Xi Y; Pillai AK
    World J Gastroenterol; 2015 Jul; 21(26):8110-7. PubMed ID: 26185383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.
    Bureau C; Garcia Pagan JC; Layrargues GP; Metivier S; Bellot P; Perreault P; Otal P; Abraldes JG; Peron JM; Rousseau H; Bosch J; Vinel JP
    Liver Int; 2007 Aug; 27(6):742-7. PubMed ID: 17617116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization.
    Chen S; Li X; Wei B; Tong H; Zhang MG; Huang ZY; Cao JW; Tang CW
    Radiology; 2013 Sep; 268(3):900-6. PubMed ID: 23657891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J; Kroencke TJ; Schuetz T; Plauth M; Kasim E; Petersein J; Schmidt HH; Lochs H
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.